{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:19:28Z","timestamp":1789031968319,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neth Heart J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>The present study aims to evaluate the efficacy and safety of the MANTA vascular closure device (VCD) (Teleflex, Morrisville, NC, USA) in transfemoral transcatheter aortic valve replacement (TF-TAVR).<\/jats:p><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>To close the femoral artery in TF-TAVR a\u00a0VCD is the treatment of choice. Data involving suture-based VCDs have been extensive. Although scarce, results on the MANTA device are promising. There is no consensus yet as to whether the MANTA device is associated with fewer access-site-related vascular\/bleeding complications when compared to suture-based VCDs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this prospective single-arm study, performed at a\u00a0single centre, a\u00a0total of 73\u00a0patients eligible for TF-TAVR were included and consecutively treated with the MANTA device.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Access-site-related vascular complications were seen in 13.7% of patients treated with the MANTA device. In this group of patients only minor vascular complications were observed. Access-site-related bleeding complications were rare (6.8%), and device failure was seen in 13.7% of the patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This single-centre study confirms that use of the MANTA device in TF-TAVR is feasible with an acceptable rate of access-site-related complications and no major vascular complications.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s12471-020-01465-3","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T14:04:09Z","timestamp":1595858649000},"page":"639-644","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Assessment of the MANTA closure device in transfemoral transcatheter aortic valve replacement: a\u00a0single-centre observational study"],"prefix":"10.1007","volume":"28","author":[{"given":"J.","family":"Halim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Missault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lycke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Van der Heyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,27]]},"reference":[{"key":"1465_CR1","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.jcin.2014.05.033","volume":"11","author":"WF Fearon","year":"2014","unstructured":"Fearon\u00a0WF, Kodali\u00a0S, Doshi\u00a0D, et\u00a0al. Outcomes after transfemoral transcatheter aortic valve replacement: a\u00a0comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registry. JACC Cardiovasc Interv. 2014;11:1245\u201351.","journal-title":"JACC Cardiovasc Interv"},{"key":"1465_CR2","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jacc.2012.07.003","volume":"60","author":"P Genereux","year":"2012","unstructured":"Genereux\u00a0P, Webb\u00a0JG, Svennson\u00a0LG, et\u00a0al. Vascular complications after transcatheter aortic valve replacement insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J\u00a0Am Coll Cardiol. 2012;60:1043\u201352.","journal-title":"J Am Coll Cardiol"},{"key":"1465_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.carrev.2016.11.004","volume":"2","author":"C Maniotis","year":"2017","unstructured":"Maniotis\u00a0C, Andreou\u00a0C, Karalis\u00a0I, Koutouzi\u00a0G, Agelaki\u00a0M, Koutouzis\u00a0M. A systematic review on the safety of Prostar XL versus ProGlide after TAVR and EVAR. Cardiovasc Revasc Med. 2017;2:145\u201350.","journal-title":"Cardiovasc Revasc Med"},{"key":"1465_CR4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.jcin.2016.12.277","volume":"10","author":"NM Van Mieghem","year":"2017","unstructured":"Van Mieghem\u00a0NM, Latib\u00a0A, Van der Heyden\u00a0J, et al. Percutaneous plug-based arteriotomy closure device for large-bore access: a\u00a0multicenter prospective study. JACC Cardiovasc Interv. 2017;10:613\u20139.","journal-title":"JACC Cardiovasc Interv"},{"key":"1465_CR5","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/ccd.27595","volume":"5","author":"R De Palma","year":"2018","unstructured":"De Palma\u00a0R, Settergen\u00a0M, Ruck\u00a0A, Linder\u00a0R, Saleh\u00a0N. Impact of percutaneous femoral arteriotomy closure using the MANTATM device on vascular and bleeding complications after transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2018;5:954\u201361.","journal-title":"Catheter Cardiovasc Interv"},{"key":"1465_CR6","doi-asserted-by":"crossref","first-page":"e007258","DOI":"10.1161\/CIRCINTERVENTIONS.119.007258","volume":"7","author":"DA Wood","year":"2019","unstructured":"Wood\u00a0DA, Krajcer\u00a0Z, Sathananthan\u00a0J, et\u00a0al. Pivotal clinical study to evaluate the safety and effectiveness of the MANTA percutaneous vascular closure device. Catheter Cardiovasc Interv. 2019;7:e7258.","journal-title":"Catheter Cardiovasc Interv"},{"key":"1465_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ijcard.2018.04.065","volume":"263","author":"F Biancari","year":"2018","unstructured":"Biancari\u00a0F, Romppanen\u00a0H, Savontaus\u00a0M, et\u00a0al. MANTA versus ProGlide vascular closure devices in transfemoral transcatheter aortic valve implantation. Int J Cardiol. 2018;263:29\u201331.","journal-title":"Int J Cardiol"},{"key":"1465_CR8","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.4244\/EIJ-D-18-00769","volume":"15","author":"N Moriyama","year":"2019","unstructured":"Moriyama\u00a0N, Lindstrom\u00a0L, Laine\u00a0M. Propensity-matched comparison of vascular closure devices after transcatheter aortic valve replacement using MANTA versus ProGlide. EuroIntervention. 2019;15:1558\u201365.","journal-title":"EuroIntervention"},{"key":"1465_CR9","first-page":"1720","volume":"17","author":"F Moccetti","year":"2019","unstructured":"Moccetti\u00a0F, Brinkert\u00a0M, Seelos\u00a0R, et\u00a0al. Insights from a\u00a0multidisciplinary introduction of the MANTA vascular closure device. JACC Cardiovasc Interv. 2019;17:1720\u201336.","journal-title":"JACC Cardiovasc Interv"},{"key":"1465_CR10","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.jacc.2012.09.001","volume":"60","author":"AP Kappetein","year":"2012","unstructured":"Kappetein\u00a0AP, Head\u00a0SJ, G\u00e9n\u00e9reux\u00a0P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium\u20112 consensus document. J\u00a0Am Coll Cardiol. 2012;60:1438\u201354.","journal-title":"J Am Coll Cardiol"},{"key":"1465_CR11","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.jcin.2016.03.010","volume":"11","author":"L Van Gils","year":"2016","unstructured":"Van Gils\u00a0L, De Jaegere\u00a0PP, Roubin\u00a0G, Van Mieghem\u00a0NM. The MANTA vascular closure device: a\u00a0novel device for large-bore vessel closure. JACC Cardiovasc Interv. 2016;11:1195\u20136.","journal-title":"JACC Cardiovasc Interv"},{"key":"1465_CR12","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jcin.2013.04.003","volume":"6","author":"S Toggweiler","year":"2013","unstructured":"Toggweiler\u00a0S, Leipsic\u00a0J, Binder\u00a0RK, et\u00a0al. Management of vascular access in transcatheter aortic valve replacement: part 1: basic anatomy, imaging, sheaths, wires, and access routes. JACC Cardiovasc Interv. 2013;6:643\u201353.","journal-title":"JACC Cardiovasc Interv"},{"key":"1465_CR13","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jcin.2011.03.019","volume":"8","author":"K Hayashida","year":"2011","unstructured":"Hayashida\u00a0K, Lefevre\u00a0T, Chevalier\u00a0B, et\u00a0al. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv. 2011;8:851\u20138.","journal-title":"JACC Cardiovasc Interv"},{"key":"1465_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jacc.2011.08.069","volume":"59","author":"S Toggweiler","year":"2012","unstructured":"Toggweiler\u00a0S, Gurvitch\u00a0R, Leipsic\u00a0J, et\u00a0al. Percutaneous aortic valve replacement: vascular outcomes with a\u00a0fully percutaneous procedure. J\u00a0Am Coll Cardiol. 2012;59:113\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"1465_CR15","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jacc.2012.07.003","volume":"12","author":"P G\u00e9n\u00e9reux","year":"2012","unstructured":"G\u00e9n\u00e9reux\u00a0P, Head\u00a0S, Van Mieghem\u00a0NM, et al. Clinical outcomes after transcatheter aortic valve replacement using Valve Academic Research Consortium definitions: a\u00a0weighted meta-analysis of 3,519 patients from 16 studies. J\u00a0Am Coll Cardiol. 2012;12:1043\u201352.","journal-title":"J Am Coll Cardiol"}],"container-title":["Netherlands Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-020-01465-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12471-020-01465-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-020-01465-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T17:45:30Z","timestamp":1667583930000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12471-020-01465-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,27]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1465"],"URL":"https:\/\/doi.org\/10.1007\/s12471-020-01465-3","relation":{},"ISSN":["1568-5888","1876-6250"],"issn-type":[{"value":"1568-5888","type":"print"},{"value":"1876-6250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,27]]},"assertion":[{"value":"27 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.\u00a0Halim, L.\u00a0Missault, M.\u00a0Lycke and J.\u00a0Van der Heyden declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}